Navigation Links
Positive Results from Phase 2 Trial of Mesoblast's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting
Date:11/14/2011

tion of heart failure hospitalization events.  Mesoblast expects that these outcomes will be central to the primary endpoint of a Revascor™ Phase 3 trial for product regulatory approval by the United States Food and Drug Administration (FDA).

The randomized, placebo-controlled 60-patient Phase 2 trial compared the safety and efficacy of three doses of Revascor™ on top of maximal approved therapies versus maximal therapies alone in patients with moderate-to-severe congestive heart failure (CHF) defined by New York Heart Association (NYHA) class II or III status and ejection fraction below 40%.  The trial enrolled both ischemic and non-ischemic heart failure patients.  Heart failure patients with this degree of severity are known to have a high cardiac mortality over a 12-24 month period despite being on maximal approved drug and device therapies.

Treatment with MPCs was well-tolerated, with 13% of patients developing transient or persistent anti-donor antibodies which were without clinical consequence. Over a 22-month mean follow-up period, only 1/45 (2%) patients who received a single injection of Revascor™ died of cardiac causes compared with 3/15 (20%) controls (p=0.02).  In addition, MPC treatment significantly delayed the time to a first Major Adverse Cardiac Event, MACE, a composite of cardiac death, heart attack or revascularization procedures (p=0.036), and reduced the overall risk for MACE by 78% (p=0.011).

Over a mean follow-up of 18 months, 0/15 patients who received the highest dose of MPC (150M) had been hospitalized for heart failure or had died.  In contrast, 3/15 (20%) controls and 6/30 (20%) patients who received low (25M) or mid (75M) doses of MPC had either been hospitalized with heart failure or had died. This clinical improvement associated with the 150M dose was accompanied by evidence of cardiac remodelling (reduction in left ventricular end systolic volumes compared with controls
'/>"/>

SOURCE Mesoblast
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Positive Data for Nektars New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011
2. Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation
3. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
4. Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
5. NeuroDerm Announces Positive Results of a Phase II Study of ND0611 Dermal Patch in Patients with Parkinsons Disease
6. Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System
7. Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheims Two Investigational HCV Direct Acting Antivirals Presented at AASLD
8. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
9. Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be Presented as a Late-Breaking Poster at the 2011 American College of Rheumatology Annual Meeting
10. Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
11. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)...  Decision Resources Group finds that ... imaging system market will be significantly driven by ... computed tomography and magnetic resonance imaging with nuclear ... the need for higher-quality imaging to satisfy more ... spur preclinical imaging system sales. Other ...
(Date:7/30/2014)... YORK and KISSING, Germany ... and distributor of a single use and computer-assisted ("robotic") ... (Homi) Shamir , a worldwide recognized medical device executive, ... Mr. Shamir is a highly respected global ... recent assignment he served as President and Chief Executive ...
(Date:7/30/2014)... 30, 2014  DigiPath, Inc. (OTCBB and OTCQB: DIGP), ... the cannabis testing and education markets, announced today that ... affairs not previously disclosed or, to its knowledge, any ... action. "We have noticed unusual price and ... trading days," said Steve Barbee , CEO of ...
Breaking Medicine Technology:Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3DigiPath No New Corporate Developments 2
... (Nasdaq CM: INSM), a biopharmaceutical company, will host a ... AM ET, to discuss its financial results for the ... quarterly financial results press release before the market opens ... the live conference call, please dial 800-901-5213 (U.S. callers) ...
... Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that ... 31, 2012, on Thursday, May 10, 2012, following the close ... investor conference call and live webcast to discuss the financial ... Time / 2:00 p.m. Pacific Time on the same date. The ...
Cached Medicine Technology:Insmed to Host 2012 First Quarter Earnings Conference Call 2Insmed to Host 2012 First Quarter Earnings Conference Call 3Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012 2Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012 3
(Date:7/30/2014)... 30, 2014 Decene is an ... chain of ten carbon atoms with one double ... of 1-decenes. It can be used as a ... to produce epoxides, amines, oxo alcohols, synthetic lubricants, ... Early buyers will receive 10% customization on this ...
(Date:7/30/2014)... 2014 (HealthDay News) -- Medical costs for chronic obstructive ... than $32 billion each year, according to new research ... The yearly financial toll of COPD (which includes ... estimated $49 billion by 2020. "For the first ... provide state public health practitioners with estimates of the ...
(Date:7/30/2014)... The global digital pathology market was valued at an estimated ... a CAGR of 11.8%, to reach an estimated $437 million ... and is expected to continue to rise in the coming ... software enable pathologists to be efficient and this leads to ... American market was valued at $128.9 million and accounted for ...
(Date:7/30/2014)... (July 30, 2014) With the advent of non-surgical ... popular science and researchers must work to ensure ... of stroke rehabilitation. A new study out today ... shift in perspective and suggests that chronically stimulating ... promote stroke motor recovery, for example by restoring ...
(Date:7/30/2014)... Rhode Island Hospital researchers have found that ... significantly reduce depression and other symptoms in informal ... with dementia. The study is published online in ... & Dementia . , "Those caring for people ... are often under a great deal of pressure," ...
Breaking Medicine News(10 mins):Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:Annual COPD Costs To Hit $49 Billion by 2020: CDC 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 4Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 5Health News:Neuro researchers advocate for a shift in thinking for stroke rehabilitation 2Health News:Study: Telephone support program beneficial for caregivers of those with dementia 2
... a nationwide increase in the incidence of injuries as a ... researchers at the Johns Hopkins Bloomberg School of Public Health ... for injuries from lawn mowing which is regarded to be ... spring. , The research also pointed out to ...
... evaluate the safety of using the amalgam fillings that contain ... health risk in children // , bringing much respite not ... to foodconsumer.org. The studies were conducted independently, one in Europe ... same conclusion about the health risks of dental amalgam in ...
... health ministry of China has reported bird flu infection in a ... and pneumonia // on 1st April has been admitted to a ... confirms the presence of bird flu infection, it would mark the ... nation. ,Since 2003, nearly 194 people have been known ...
... Health officials declared on Tuesday in Guwahati that, at least ... northeast India and another 25,000 have fallen sick from the ... Assam state government announced that since the beginning of April, ... two districts in the eastern part of the state Lakhmipur ...
... study titled 'Search for Diabetes in Youth' has highlighted the ... points out to the importance of keeping a constant vigil ... prevent the associated complications. The results of the study have ... official journal of the Juvenile Diabetes Research Foundation. ...
... earn for meeting specific targets like children's vaccinations. While there ... ?250,000.// ,The elevation in GP’s pay is after the ... as GPs historically earned less than hospital doctors, and trainee ... the perceived high workload and a responsibility for 24-hour cover. ...
Cached Medicine News:Health News:Nationwide Increase In Lawn Mowing Injuries 2Health News:Dental Amalgam Doesn't Pose Health Risks In Children 2Health News:Dental Amalgam Doesn't Pose Health Risks In Children 3Health News:Dental Amalgam Doesn't Pose Health Risks In Children 4Health News:14% Of Pune Population Diabetic: Children Most Affected 2
... Nanopipetting System Genesis NPS based on the ... you to miniaturize your assays for high ... and direct dilutions., Furthermore it is ... including gene expression analysis, gene mapping, SNP ...
... is a reagent dispensing system designed to ... microplates. This dispenser can be equipped with ... orifice nozzle heads. Precise plate positioning and ... to a variety of plate types including ...
... Dispenses volumes down to 0.5ul for 384 ... less than 30 seconds per plate significantly ... user interface that provides one-button dispensing. It ... suspensions, beads, or cells, with high precision ...
... QFill2 is the ideal system for fast, accurate ... pressure driven, pinch valve controlled dispensing mechanism, ensures ... all of the components that come into contact ... clean, and autoclave. The unique compact design saves ...
Medicine Products: